This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Medtronic Vascular, Inc., University of Virginia Patent Foundation. Active years: 2010-2017.
Company Filing History:
3 out of 1,006 
1 out of 1,040 
Years Active: 2010-2017
Title: Innovations by Joshua Spradlin
Introduction
Joshua Spradlin is an accomplished inventor based in Charlottesville, VA (US). He has made significant contributions to the field of medical devices, particularly in the development of vascular stents. With a total of 4 patents to his name, Spradlin's work focuses on enhancing the functionality and biocompatibility of implantable medical devices.
Latest Patents
One of Spradlin's latest patents is for nanoporous stents with enhanced cellular adhesion and reduced neointimal formation. This invention relates to medical devices that feature nanoporous surfaces, specifically designed to improve healing and long-term biocompatibility. The nanoporous layer promotes re-endothelialization at stent implantation sites, thereby improving overall healing and reducing inflammation. Additionally, the layer can be loaded with therapeutic agents to further enhance the stent's clinical efficacy. Another patent involves methods for using stents with porous layers, which are adapted to resist stenosis or cellular proliferation.
Career Highlights
Throughout his career, Joshua Spradlin has worked with notable organizations such as Medtronic Vascular, Inc. and the University of Virginia Patent Foundation. His experience in these institutions has allowed him to refine his expertise in medical device innovation.
Collaborations
Spradlin has collaborated with esteemed colleagues, including Gary Owens and Brian R. Wamhoff. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Joshua Spradlin's innovative work in the field of medical devices, particularly with nanoporous stents, showcases his commitment to improving patient outcomes. His contributions continue to influence the landscape of biomedical engineering.